… in Parkinson's drug development and innovative research from the Foundation's portfolio. David Standaert, MD, PhD, … Pipeline Thomas Foltynie, PhD, MD, MRCP, shared results from an MJFF-funded Phase II trial evaluating the injectable … MD, MS, Voyager Therapeutics, reported interim results from an ongoing Phase Ib, open-label trial testing a gene …

… Council launched a petition to ban the use of the herbicide paraquat, which is associated with PD. If you haven't done …

… using a structured prioritization framework stemming from efforts across the field, including rich target inputs from MJFF research program datasets and collaboration with … With the selection process complete, T2T is now shifting from target identification to active validation. MJFF has …

… From left to right: Alexandria, Kate, Duyen and Kylie at … up for the community-led events that power our mission. From rides and races to long-running fundraisers marking … see how the Team Fox community mobilizes coast to coast — from the SoCal Ride 4 Parkinson’s in Irvine, California, t o …

… This grant builds upon the research from a prior grant: Mechanism and Modulation of … alpha-synuclein expression relative to neurons derived from wild-type embryonic stem cells, thus supporting our …